Complementary and alternative therapies: Use in pediatric pulmonary medicine

Pediatric Pulmonology

Volumn 46, Issue 6, 2011, Pages 530-544

  Chung, Youngran ^a,c   Dumont, Robert C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Raby Institute for Integrative Medicine at Northwestern LLC   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

alternative medicine; children; complementary medicine; integrative medicine; pulmonary disorders

Indexed keywords

ASCORBIC ACID; AYURVEDIC DRUG; BOSWELLIA SERRATA EXTRACT; CORTICOSTEROID; CURCUMIN; DOCOSAHEXAENOIC ACID; EPHEDRA SINICA EXTRACT; GAMMA LINOLENIC ACID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GRINDELIA CAMPORUM EXTRACT; ICOSAPENTAENOIC ACID; LOBELIA EXTRACT; MAGNESIUM; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PETASITES HYBRIDUS EXTRACT; PLACEBO; PLANT EXTRACT; PROBIOTIC AGENT; PYCNOGENOL; SANGUINARIA EXTRACT; SELENIUM; TYLOPHORA EXTRACT; UNCLASSIFIED DRUG;

ACUPUNCTURE; ADD ON THERAPY; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTICLE; ASTHMA; ATOPY; AYURVEDA; BRONCHIECTASIS; CHINESE MEDICINE; CHIROPRACTIC; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIARRHEA; DIET THERAPY; DIETARY INTAKE; DRUG FATALITY; ENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GRINDELIA; HEALTH PRACTITIONER; HEART ARRHYTHMIA; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERTENSION; ILEUS; INFLUENZA; IRRITABLE COLON; LIFESTYLE MODIFICATION; LOBELIA; LUNG FIBROSIS; MASSAGE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SANGUINARIA; SEIZURE; TREATMENT CONTRAINDICATION; TYLOPHORA;

CHILD; CHRONIC DISEASE; COMPLEMENTARY THERAPIES; HUMANS; LUNG DISEASES; PULMONARY MEDICINE; TREATMENT OUTCOME;

EID: 79955906957     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21426     Document Type: Article

References (152)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL,. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246-252. (Pubitemid 23035311)
2. Kemper JK, Vohra S, Walls R,. The task force on complementary medicine and alternative medicine and the provisional section on complementary, holistic and alternative medicine. The use of Complementary and Alternative Medicine in Pediatrics. Pediatrics 2008; 122: 1374-1386.
3. Mark JD,. Integrative medicine and asthma. Pediatr Clin N Am 2007; 54: 1007-1023. (Pubitemid 350179895)
4. Ernst E,. Use of complementary therapies in childhood asthma. Pediat Asthma Allergy Immunol 1998; 12: 29-32. (Pubitemid 28334068)
5. Stern RC, Canda ER, Doershuk C,. Use of nonmedical treatment by cystic fibrosis patients. J Adolescent Health 1992; 13: 612-615.
6. Ramsay D, Bowman M, Greenman P, Jiang S, Kushi L, Leeman S, Lin K, Moerman D, Schnoll S, Walker M, et al. National Institute of Health Consensus Development Conference Statement. Acupuncture 1997; 15: 1-34.
7. World Health Organization. Traditional Chinese Medicine and Acupuncture Health Information Organization: acupuncture research: review and analysis of reports on controlled clinical trials. World Health Organization. 2003.
8. Jobst KA,. Acupuncture in asthma and pulmonary disease: an analysis of efficacy and safety. J Altern Complement Med 1996; 2: 179-206. (Pubitemid 126488130)
9. McCarney RW, Brinkhaus B, Lasserson TJ, Linde K,. Acupuncture for chronic asthma. Cochrane Database Syst Rev 2004; 1: CD000008.
10. Fleischman GF,. Possibilities for the treatment of cystic fibrosis with acupuncture and Chinese herbs: theory and case study. Am J Acupunct 1996; 24: 135-142. (Pubitemid 26304056)
11. Maa S, Tsou T, Wang K, Wang C, Lin H, Huang Y,. Self administered acupressure reduces the symptoms that limit daily activity in bronchiectasis patients. J Clin Nurs 2007; 16: 794-804.
12. Maa S, Sun M, Hsu K, Hung T, Chen H, Yu C, Wang C, Lin H,. Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study. J Altern Complement Med 2003; 9: 659-670. (Pubitemid 37377386)
13. Manheimer E, Cheng K, Linde K, Lao L, Yoo J, Wieland S, van der Windt DA, Berman BM, Bouter LM,. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev 2010; 1: CD001977.
14. Lewis K, Abdi S,. Acupuncture for lower back pain: a review. Clin J Pain 2010; 26: 60-69.
15. Lin JG, Chen WL,. Review: acupuncture analgesia in clinical trials. Am J Chin Med 2009; 37: 1-18.
16. Selfe TK, Taylor AG,. Acupuncture and osteoarthritis of the knee: a review of randomized, controlled trials. Fam Community Health 2008; 31: 247-254.
17. Madsen MV, Gøtzsche PC, Hrõbjartsson A,. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. Br Med J 2009; 338: a3115.
18. Sun Y, Gan TJ,. Acupuncture for the management of chronic headache: a systematic review. Anesth Analg 2008; 107: 2038-2047.
19. Sun Y, Gan TJ, Dubose JW, Habib AS,. Acupuncture and related techniques for postoperative pain: a systematic review of randomized controlled trials. Br J Anaesth 2008; 101: 151-160. (Pubitemid 351989668)
20. Lin YC, Ly H, Golianu B,. Acupuncture pain management for patients with cystic fibrosis: a pilot study. Am J Chin Med 2005; 33: 151-156. (Pubitemid 40468313)
21. Loo M,. Acupuncture. In:, Loo M, editor. Integrative medicine for children. Saunders: Elsevier; 2009. p 81.
22. White A,. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med 2004; 22: 122-133. (Pubitemid 40012600)
23. Carson C, Riley T,. Toxicity of the essential oil of Melaleuca alternifolia or tea tree oil. J Toxicol Clin Toxicol 1995; 33: 193-194.
24. Ernst H,. Herbal medicines for asthma: a systematic review. Thorax 2000; 55: 925-929.
25. Clark CE, Arnold E, Lasserson TJ, Wu T,. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J 2010; 19: 307-314. pii: pcrj-2010- 04-0047. DOI: 10.4104/pcrj.2010. 00041 [Epub ahead of print]. Available on.
26. Ammon HP,. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 72: 1100-1116. (Pubitemid 44638909)
27. Ernst E,. Frankincense: systematic review. Br Med J 2008; 337: 1439-1441.
28. Moussaieff A, Mechoulam R,. Boswellia resin from religious ceremonies to medical uses: a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol 2009; 61: 1281-1293.
29. Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP,. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6 week clinical study. Eur J Med Res 1998; 3: 511-514.
30. Gopalakrishnan C, Shankaranarayan D, Kameswaran L, Natarajan S,. Pharmacological investigations of tylophorine, the major alkaloid of Tylophora indica. Indian J Med Res 1979; 69: 513-520. (Pubitemid 9159479)
31. Gopalakrishnan C, Shankaranarayan D, Nazimudeen SK, Kameswaran L,. Effect of tylophorine, a major alkaloid of Tylophora indica, on immunopathological and inflammatory reactions. Indian J Med Res 1980; 71: 940-948. (Pubitemid 11213904)
32. Ganguly T, Sainis KB,. Inhibition of cellular immune responses by Tylophora indica in experimental models. Phytomedicine 2001; 8: 348-355. (Pubitemid 32983054)
33. Udupa AL, Udupa SL, Guruswamy MN,. The possible site of anti-asthmatic action of Tylophora asthmatica on pituitary-adrenal axis in albino rats. Planta Med 1991; 57: 409-413.
34. Shivpuri DN, Menon MP, Prakash D,. A crossover double-blind study on Tylophora indica in the treatment of asthma and allergic rhinitis. J Allergy 1969; 43: 145-150.
35. Shivpuri DN, Singhal SC, Parkash D,. Treatment of asthma with an alcoholic extract of Tylophora indica: a crossover, double-blind study. Ann Allergy 1972; 30: 407-412.
36. Mathew KK, Shivpuri DN,. Treatment of asthma with alkaloids of Tylophora indica: a double-blind study. Aspects Allergy Appl Immunol 1974; 7: 166-179.
37. Thiruvengadam KV, Haranath K, Sudarsan S, Sekar TS, Rajagopal KR, Zacharian MG, Devarajan TV,. Tylophora indica in bronchial asthma. J Indian Med Assoc 1978; 71: 172-177.
38. Gupta S, George P, Gupta V, Tandon VR, Sundaram KR,. Tylophora indica in bronchial asthma-a double-blind study. Indian J Med Res 1979; 69: 981-989. (Pubitemid 9239262)
39. Wang W, Bernard K, Li G, Kirk KL,. Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem 2007; 16: 4533-4544. (Pubitemid 47100973)
40. Menon VP, Sudheer AR,. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 2007; 595: 105-125.
41. Sharma RA, Steward WP, Gescher AJ,. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 2007; 595: 453-470.
42. Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM,. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm 2010; 7: 86-93.
43. Thomet OA, Schapowal A, Heinisch IV, Wiesmann UN, Simon HU,. Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol 2002; 2: 997-1006. (Pubitemid 34756390)
44. Danesch UC,. Petasites hybridus (Butterbur root) extract in the treatment of asthma-an open trial. Alter Med Rev 2004; 9: 54-62.
45. Lee DK, Haggart K, Robb FM, Lipworth BJ,. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy 2004; 34: 110-114. (Pubitemid 38183688)
46. Persson T, Hansen TH, Rasmussen TB, Skindersø ME, Givskov M, Nielsen J,. Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic. Org Biomol Chem 2005; 3: 253-262. (Pubitemid 40162748)
47. Bjarnsholt T, Jensen PØ, Rasmussen TB, Christophersen L, Calum H, Hentzer M, Hougen HP, Rygaard J, Moser C, Eberl L, Høiby N, Givskov M,. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 2005; 151: 3873-3880. (Pubitemid 41829968)
48. Smyth AR, Cifelli PM, Ortori CA, Righetti K, Lewis S, Erskine P, Holland ED, Givskov M, Williams P, Cámara M, Barrett DA, Knox A,. Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis - a pilot randomized controlled trial. Pediatr Pulmonol 2010; 45: 356-362.
49. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ,. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trial 1996; 17: 1-12. (Pubitemid 26120810)
50. Jane Brody: vitamins and supplements. New York Times 1997. October 26.
51. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE,. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843-847.
52. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML,. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001; 20: 157-165. (Pubitemid 32423606)
53. Back EI, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, Ranke M, Biesalski HK,. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr 2004; 80: 374-384. (Pubitemid 41080011)
54. Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC,. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003; 2: 195-198. (Pubitemid 37376497)
55. Lands LC, Iskandar M, Beaudoin N, Meehan B, Dauletbaev N, Berthiuame Y,. Dietary supplementation with pressurized whey in patients with cystic fibrosis. J Med Food 2010; 13: 77-82.
56. Zavorsky GS, Kubow S, Grey V, Riverin V, Lands LC,. An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int J Food Sci Nutr 2007; 58: 429-436. (Pubitemid 47316886)
57. Kongerud J, Crissman K, Hatch G, Alexis N,. Ascorbic acid is decreased in induced sputum of mild asthmatics. J Inhal Toxicol 2003; 15: 101-109. (Pubitemid 36222333)
58. Allen S, Britton JR, Leonardi-Bee JA,. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 2009; 64: 610-619.
59. Gao J, Gao X, Li W, Zhu Y, Thompson PJ,. Observational studies on the effect of dietary antioxidants on asthma: a meta-analysis. Respirology 2008; 13: 528-536. (Pubitemid 351725282)
60. Kaur B, Rowe BH, Arnold E,. Vitamin C supplementation for asthma. Cochrane Database Syst Rev 2009; 21: CD000993.
61. Wood LG, Fitzgerald DA, Lee AK, Garg ML,. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 2003; 77: 150-159. (Pubitemid 36015385)
62. Shaheen SO, Newson RB, Rayman MP, Wong AP, Tumilty MK, Phillips JM, Potts JF, Kelly FJ, White PT, Burney PG,. Randomised double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax 2007; 62: 483-490. (Pubitemid 46910125)
63. Hasselmark L, Malmgren R, Zetterstrom O, Unge G,. Selenium supplementation in intrinsic asthma. Allergy 1998; 48: 30-36. (Pubitemid 23048207)
64. Allam MF, Lucance RA,. Selenium supplementation for asthma. Cochrane Database Syst Rev 2004; 2: CD003538.
65. Duntas LH,. Selenium F inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 2009; 41: 443-447.
66. Lau BH, Riesen SK, Truong KP, Lau EW, Rohdewald P, Barreta RA,. Pycnogenol as an adjunct in the management of childhood asthma. J Asthma 2004; 41: 825-832. (Pubitemid 40019134)
67. Hosseini S, Pishnamazi S, Sadrzadeh SM, Farid F, Farid R, Watson RR,. Pycnogenol® in the management of asthma. J Med Food 2001; 4: 201-209.
68. Simopoulos AP,. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70: 560S-569S. (Pubitemid 29407138)
69. Wall R, Ross RP, Fitzgerald GF, Stanton C,. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68: 280-289.
70. McKarney C, Everard M, N'Diaye T,. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2007; 17: CD002201.
71. Reisman J, Schachter HM, Dales RE, Tran K, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury I, Blackman J,. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med 2006; 19: 6-26.
72. Woods RK, Thien FC, Abramson MJ,. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2002; 3: CD001283.
73. Olveira G, Olveira C, Acosta E, Espíldora F, Garrido- Sánchez L, García-Escobar E, Rojo-Martínez G, Gonzalo M, Soriguer F,. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch Bronconeumol 2010; 46: 70-77.
74. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S,. Dietary magnesium, lung function, wheezing and airway hyperreactivity in a random population sample. Lancet 1994; 344: 357-362. (Pubitemid 24248206)
75. Rowe BH, Camargo CA, Jr., The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulm Med 2008; 14: 70-76. (Pubitemid 350191041)
76. Gontijo-Amaral C, Ribeiro MA, Gontijo LS, Condino-Neto A, Ribeiro JD,. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. Eur J Clin Nutr 2007; 61: 54-60. (Pubitemid 44929327)
77. Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A,. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20: 813-819. (Pubitemid 39319237)
78. Infante Pina D, Redecillas Ferreiro S, Torrent Vernetta A, Segarra Cantõn O, Maldonado Smith M, Gartner Tizziano L, Hidalgo Albert E,. Improvement of intestinal function in cystic fibrosis patients using probiotics. An Pediatr (Barc) 2008; 69: 501-505.
79. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, Guarino A,. Effect of lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007; 26: 322-328. (Pubitemid 46760477)
80. Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O,. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010; 45: 536-540.
81. Honeycutt TC, El Khashab M, Wardrop RM III, McNeal-Trice K, Honeycutt AL, Christy CG, Mistry K, Harris BD, Meliones JN, Kocis KC,. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8: 452-458. (Pubitemid 47415298)
82. Whelan K, Myers CE,. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010; 91: 687-703.
83. Liong MT,. Safety of probiotics: translocation and infection. Nutr Rev 2008; 66: 192-202.
84. Snydman DR,. The safety of probiotics. Clin Infect Dis 2008; 1: S104-S111. (Pubitemid 351323676)
85. Rey L,. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A 2003; 323: 67-74.
86. Elia V, Niccoli M,. New physico-chemical properties of extremely diluted aqueous solutions. J Therm Anal Calorimetry 2004; 75: 815-836.
87. Roy R, Tiller WA, Bell IR, Hoover MR,. The structure of liquid water; novel insights from materials research; potential relevance to homeopathy. Mater Res Innov 2005; 94: 577-608.
88. Rao ML, Roy R, Bell IR, Hoover R,. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy 2007; 96: 175-182. (Pubitemid 47126997)
89. Belon P, Cumps J, Ennis M, Mannaioni PF, Sainte-Laudy J, Roberfroid M, et al. Histamine dilutions modulate basophil activity. Inflamm Res 2004; 53: 181-188. (Pubitemid 38626447)
90. Witt CM, Bluth M, Albrecht H, et al. The in vitro evidence for an effect of high homeopathic potencies-a systematic review of the literature. Complement Ther Med 2007; 15: 128-138. (Pubitemid 46850587)
91. Frenkel M, Mishra BM, Sen S, Yang P, Pawlus A, Vence L, Leblanc A, Cohen L, Banerji P, Banerji P,. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 2010; 36: 395-403.
92. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB,. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 20: 834-843. (Pubitemid 27404344)
93. Kleijnen J, Knipschild P, ter Riet G,. Clinical trials of homeopathy. Br Med J 1991; 302: 316-323.
94. Cucherat M, Haugh MC, Gooch M, Boissel JP,. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur J Clin Pharmacol 2000; 56: 27-33.
95. Shang A, Huwiler-Müntener K, Nartey L, Jüni P, Dörig S, Sterne JA, Pewsner D, Egger M,. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 2: 726-732. (Pubitemid 41207234)
96. Rutten AL, Stolper CF,. The 2005 meta-analysis of homeopathy: the importance of post-publication data. Homeopathy 2008; 97: 169-177.
97. Reilly D, Taylor MA, McSharry C, Aitchison TC,. Is homeopathy a placebo response? Controlled trial of homeopathic potency, with pollen in hayfever as model. The Lancet 1986; 344: 881-886. (Pubitemid 17170641)
98. Reilly D, Taylor MA, Beattie NG, Campbell JH, McSharry C, Aitchison TC, Carter R, Stevenson RD,. Is evidence for homeopathy reproducible? The Lancet 1994; 344: 1601-1606.
99. Vickers AJ, Smith C,. Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database Syst Rev 2000; 3: CD001957.
100. Barnes J, Resch KL, Ernst E,. Homeopathy for postoperative ileus? A meta-analysis. J Clin Gastoenterol 1997; 25: 628-633.
101. Jacobs J, Jimenez LM, Gloyd SS, Gale JL, Crothers D,. Treatment of acute childhood diarrhea with homeopathic medicine: a randomized clinical trial in Nicaragua. Pediatrics 1994; 93: 719-725. (Pubitemid 24136102)
102. Jacobs J, Jonas WB, Jimenez-Perez M, Crothers D,. Homeopathy for childhood diarrhea: combined results and meta-analysis from three randomized controlled trials. Pediatr Infect Dis 2003; 22: 229-234. (Pubitemid 36351070)
103. Linde K, Jobst KA,. Homeopathy for chronic asthma. Cochrane Database Syst Rev 2000; 1: CD000353.
104. Frass M, Dielacher C, Linkesch M, et al. Influence of potassium dichromate on tracheal secretions in critically ill patients. Chest 2005; 127: 936-941. (Pubitemid 40775527)
105. Dantas F, Rampes H,. Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J 2000; 89: 235-238.
106. Haczku A, Panettieri RA, Jr., Social stress and asthma: the role of corticosteroid insensitivity. J Allergy Clin Immunol 2010; 125: 550-558.
107. Chen E, Miller GE,. Stress and inflammation in exacerbations of asthma. Brain Behav Immun 2007; 21: 993-999. (Pubitemid 47484388)
108. Chen E, Hanson M, Paterson L, et al. Socioeonomic status and inflammatory processes in childhood asthma: the role of psychological stress. J Allergy Clin Immunol 2006; 117: 1014-1020.
109. Cohen DP,. A pediatric perspective on mind-body medicine. In:, Culbert TP, Olness K, editors. Integrative Pediatrics. New York: Oxford University Press; 2010. pp. 267-301.
110. NIH Technol Assess Statement. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. NIH Technol Assess Statement. 1995; October 16-18: 1-34.
111. Anbar R, Hummell K,. Teamwork approach to clinical hypnosis at a pediatric pulmonary center. Am J Clin Hypn 2005; 48: 45-49. (Pubitemid 41278306)
112. Anbar RD,. Self-hypnosis for management of chronic dyspnea in pediatric patients. Pediatrics 2001; 107: E21.
113. Belsky J, Khanna P,. The effects of self-hypnosis for children with cystic fibrosis: a pilot study. Am J Clin Hypn 1994; 36: 282-292. (Pubitemid 24099208)
114. Anbar RD,. Self-hypnosis for patients with cystic fibrosis. Pediatr Pulmonol 2000; 30: 461-465.
115. Brown D,. Evidence-based hypnotherapy for asthma: a critical review. Int J Clin Exp Hypn 2007; 55: 220-249. (Pubitemid 46340983)
116. Lahmann C, Nickel M, Schuster T, Sauer N, Ronel J, Noll-Hussong M, Tritt K, Nowak D, Rohricht F, Loew T,. Functional relaxation and guided imagery as complementary therapy in asthma: a randomized controlled clinical trial. Psychother Psychosom 2009; 78: 233-239.
117. Delk KK, Gevirtz R, Hicks DA, Carden F, Rucker R,. The effects of biofeedback assisted breathing retraining on lung functions in patients with cystic fibrosis. Chest 1994; 105: 23-28. (Pubitemid 24029070)
118. Grasso M, Button BM, Allison DJ, Sawyer SM,. Benefits of music therapy as an adjunct to chest physiotherapy in infants and toddlers with cystic fibrosis. Pediatr Pulmonol 2000; 29: 371-381. (Pubitemid 30230425)
119. Holloway E, Ram F,. Breathing exercises for asthma. Cochrane Database Syst Rev 2004; 1: CD001277.
120. Pomidori L, Campigotto F, Amatya TM, Bernardi L, Cogo A,. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev 2009; 29: 133-137.
121. Vempati R, Bijlani RL, Deepak KK,. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial. BMC Pulm Med 2009; 30: 37.
122. Sodhi C, Singh S, Dandona PK,. A study of the effect of yoga training on pulmonary functions in patients with bronchial asthma. Indian J Physiol Pharmacol 2009; 53: 169-174.
123. Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V,. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med 2009; 15: 225-234.
124. Galantino ML, Galbavy R, Quinn L,. Therapeutic effects of yoga for children: a systematic review of the literature. Pediatr Phys Ther 2008; 20: 66-80. (Pubitemid 351317347)
125. Sabina AB, Williams AL, Wall HK, Bansal S, Chupp G, Katz DL,. Yoga intervention for adults with mild-to-moderate asthma: a pilot study. Ann Allergy Asthma Immunol 2005; 94: 543-548. (Pubitemid 40712777)
126. Cooper S, Oborne J, Newton S, Harrison V, Thompson Coon J, Lewis S, Tattersfield A,. Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled trial. Thorax 2003; 58: 674-679. (Pubitemid 36976276)
127. Haldeman S,. Principles and practice of chiropractic. New York: McGraw-Hill Professional; 2004. p. 755.
128. Bonfort G, Evans R, Kubic P, Filkin P,. Chronic pediatric asthma and chiropractic spinal manipulation: a prospective clinical series and randomized clinical pilot study. J Manipulative Physiol Ther 2001; 24: 369-377. (Pubitemid 32800481)
129. Kaminskyj A, Frazier M, Johnstone K, Gleberzon J,. Chiropractic care for patients with asthma: a systematic review of the literature. J Can Chiropr Assoc 2010; 54: 24-32.
130. Stern RC, Canda ER, Doershuk CF,. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992; 13: 612-615.
131. Thiel HW, Bolton JE, Docherty S, Portlock JC,. Safety of chiropractic manipulation of the cervical spine: a prospective national survey. Spine 2007; 32: 2375-2378. (Pubitemid 47508847)
132. Gouveia LO, Castanho P, Ferreira JJ,. Safety of chiropractic interventions: a systematic review. Spine 2009; 15: E405-E413.
133. Vohra S, Johston BC, Cramer K, Humphreys K,. Adverse events associated with pediatric spinal manipulation: a systematic review. Pediatrics 2007; 119: 275-283.
134. Paccou J, Zeboulon N, Combescure C, Gossec L, Cortet B,. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010; 86: 1-7.
135. Field T, Hernandez-Reif M, Diego M, Figueiredo B, Schanberg S, Kuhn C,. Prenatal cortisol, prematurity and low birthweight. Infant Behav Dev 2006; 29: 268-275. (Pubitemid 43264517)
136. Hernandez-Reif M, Field T, Krasnegor J, Martinez E, Schwartzman M, Mavanda K,. Children with cystic fibrosis benefit from massage therapy. J Pediatr Psychol 1999; 24: 175-181. (Pubitemid 29177426)
137. Field T, Henteleff T, Hernandez-Reif M, et al. Children with asthma have improved pulmonary function after massage therapy. J Pediatr 1998; 132: 854-858. (Pubitemid 28232940)
138. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC,. Trends in alternative medicine use in the Unites States 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575. (Pubitemid 28520643)
139. Roberts L, Ahmed I, Hall S, Davison A,. Intercessory prayer for the alleviation of ill health. Cochrane Database Syst Rev 2009; 2: CD000368.
140. Ott MJ, Bossi I, Colbath J,. A pediatric perspective on energy therapies. In:, Culbert TP, Olness K, editors. Integrative pediatrics. New York: Oxford University Press; 2010. pp. 180-203.
141. Rosa L, Rosa E, Sarner L, Barrett S,. A close look at therapeutic touch. JAMA 1998; 279: 1005-1010. (Pubitemid 28172999)
142. Cox T,. A nurse-statistician reanalyzes data from the Rosa therapeutic touch study. Altern Ther Health Med 2003; 9: 58-64. (Pubitemid 36119755)
143. Dossey L,. Therapeutic touch at the crossroads: observations on the Rosa study. Altern Ther Health Med 2003; 9: 38-39. (Pubitemid 36119752)
144. Achterberg J,. Clearing the air in the therapeutic touch controversy. Altern Ther 1998; 4: 100-101.
145. Leskowitz E,. Un-debunking therapeutic touch. Altern Ther 1998; 4: 101-102.
146. Wardell D, Engebretson J,. Biological correlates of Reiki Touch (sm) healing. J Adv Nurs 2001; 33: 439-445. (Pubitemid 33615636)
147. Ng BH, Tsang HW,. Psychophysiological outcomes of health qigong for chronic conditions: a systematic review. Psychophysiology 2009; 46: 257-269.
148. Taylor-Piliae RE,. The effectiveness of Tai Chi exercise in improving aerobic capacity: an updated meta-analysis. Med Sport Sci 2008; 52: 40-53.
149. Lee MS, Lee EN, Ernst E,. Is Tai Chi beneficial for improving aerobic capacity? A systematic review. Br J Sports Med 2009; 43: 569-573.
150. Shekelle PG, Morton SC, Suttorp MJ, Buscemi N, Friesen C,. Challenges in systematic reviews of complementary and alternative medicine topics. Ann Intern Med 2005; 142: 1042-1047. (Pubitemid 40847706)
151. Mason S, Tovey P, Long AF,. Evaluating complementary medicine: methodological challenges of randomised controlled trials. Br Med J 2002; 325: 832-834. (Pubitemid 35177981)
152. Pham B, Klassen TP, Lawson ML, Moher D,. Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. J Clin Epidemiol 2005; 58: 769-776. (Pubitemid 40966834)